|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 425 THIRD STREET, SW |
Address2 | SUITE 875 |
City | WASHINGTON |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 290137-12
|
||||||||
|
6. House ID# 371570000
|
TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Chris Swonger |
Date | 4/19/2016 3:35:59 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
FY2017 National Defense Authorization Act. FY2017 Department of Defense Appropriations; P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures. Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and detection solutions for the Department of Defense.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Guard, Defense - Dept of (DOD), Army - Dept of (Other)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Schmidt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Chris |
Swonger |
|
|
|
Kevin |
Schmidt |
|
|
|
Lisa |
Ceglia |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
Issues related to aviation security solutions and detection technologies for the Transportation Security Administration (TSA), Department of Homeland Security (DHS) and U.S. Customs and Border Protection (CBP). Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and other border security solutions. FY2017 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding issues.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), Transportation Security Administration (TSA), U.S. Customs & Border Protection
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Schmidt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AVI
16. Specific lobbying issues
Aviation security solutions and detection technologies for the Transportation Security Administration (TSA).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), Transportation Security Administration (TSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Schmidt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for aviation security and homeland security technologies. FY2017 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding issues. FY2017 Department of Defense Appropriations; chemical and biological counter measures. FY2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; medical device funding and policy. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Defense - Dept of (DOD), Homeland Security - Dept of (DHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Schmidt |
|
|
|
Chris |
Swonger |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act; P.L.114-113, Protecting Americans from Tax Hikes Act of 2015 and Consolidated Appropriations Act, 2016. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Chris |
Swonger |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
Issues related to climate change and emissions technologies.
17. House(s) of Congress and Federal agencies Check if None
Energy - Dept of, Environmental Protection Agency (EPA), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Chris |
Swonger |
|
|
|
Lisa |
Ceglia |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Chris |
Swonger |
|
|
|
Lisa |
Ceglia |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lisa |
Ceglia |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |